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Background: Although there is extensive evidence for the amoeboid invasiveness of cancer cells in vitro, much
less is known about the role of amoeboid invasiveness in metastasis and the importance of Rho/ROCK/MLC
signaling in this process.
Results: We analyzed the dependence of amoeboid invasiveness of rat and chicken sarcoma cells and the
metastatic activity of chicken cells on individual elements of the Rho/ROCK/MLC pathway. In both animal models,
inhibition of Rho, ROCK or MLC resulted in greatly decreased cell invasiveness in vitro, while inhibition of
extracellular proteases using a broad spectrum inhibitor did not have a significant effect. The inhibition of both Rho
activity and MLC phosphorylation by dominant negative mutants led to a decreased capability of chicken sarcoma
cells to metastasize. Moreover, the overexpression of RhoA in non-metastatic chicken cells resulted in the rescue of
both invasiveness and metastatic capability. Rho and ROCK, unlike MLC, appeared to be directly involved in the
maintenance of the amoeboid phenotype, as their inhibition resulted in the amoeboid-mesenchymal transition in
analyzed cell lines.
Conclusion: Taken together, these results suggest that protease-independent invasion controlled by elements of
the Rho/ROCK/MLC pathway can be frequently exploited by metastatic sarcoma cells.
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Cancer metastasis is a multistage process composed of
series of phenotypic and biochemical changes, including
altered gene expression, angiogenesis, lymphangiogene-
sis, motility and cell shape [1]. During the first step of
metastatic spreading, the malignant tumor cells initiate
separation from the primary tumor mass and break
contacts with neighboring cells. Then, the tumor cells
degrade and penetrate the extracellular matrix and enter
the bloodstream or lymphatic system, from where they
can exit at a new site and proliferate in secondary organs
[2]. The most critical steps in metastasis are the cell
migration and cell invasion that are responsible for the
malignancy of tumor cells invading the surrounding
tissues [3-5]. This is represented by dynamic filamentous* Correspondence: brabek@natur.cuni.cz
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reproduction in any medium, provided the oractin cytoskeletal remodeling, which enables tumor cells
to adhere to the extracellular matrix and generate intra-
cellular forces for cell movement [3-5]. Actin remodeling
and the whole process of cell movement are regulated
by small GTPases of the Rho family, mainly RhoA,
RhoC, cdc42 and Rac [6,7]. Nevertheless the capacity of
tumor cells to invade adjacent tissues depends on
specific migratory mechanisms.
There are two main types of movements adopted by
tumor cells, amoeboid and mesenchymal, and it has
been shown that the Rho/ROCK and Rac signaling path-
ways are critical for both [8,9]. Mesenchymal movement
requires integrin attachment to the extracellular matrix,
the formation of strong focal contacts, and pericellular
proteolysis. Cells migrating by the mesenchymal mode
also display an elongated morphology in the three-
dimensional (3D) environment [10]. In contrast, some
tumor cells can move with an amoeboid, rounded shape
that is associated with the formation of small membrane
blebs and cortical actin [9]. In amoeboid tumor cells thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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leads to the increased generation of traction forces [11],
allowing the amoeboid cells to push through the extra-
cellular matrix independently of extracellular matrix
degradation [11,12]. ROCK kinase is subsequently sug-
gested to affect the traction forces by phosphorylation of
the myosin light chain (MLC), which activates acto-
myosin contractility [13,14].
Although there is extensive evidence for the amoeboid
invasiveness of cancer cells in vitro [15] and its depen-
dence on Rho/ROCK/MLC signaling [9], much less is
known about the plausibility of amoeboid invasiveness
and metastasis in vivo and the importance of Rho/
ROCK/MLC signaling in this process [12,16,17]. In this
study we analyzed the role of the individual components
of Rho/ROCK/MLC signaling for morphology, invasion
and, importantly, also for the metastatic potential of
amoeboid sarcoma cells.
Results
The Rho/ROCK/MLC pathway is critical for the invasion of
highly metastatic rat A3 cells into the 3D collagen matrix
and acellular dermis
In our previous study [11], we showed for the first time
that highly metastatic A3 rat sarcoma cells use the Rho/
ROCK-dependent amoeboid mode of invasion as their
primary invading mechanism. Furthermore, we showed
that the up-regulation of Rho/ROCK signaling results in
an increased invasion into Matrigel associated with the
increased activation of Rho and recruitment of the
phosphorylated myosin light chain (MLC) to the lead-
ing edge of the cell. To elucidate the role of individual
components of Rho/ROCK/MLC signaling in the
amoeboid invasiveness of sarcoma cells, cell lines were
prepared to stably express either GFP-tagged dnRhoA
(A3dnRho; inactivating mutation T19N) or GFP-tagged
non-phosphorylable (dominant negative) MLC (A3dnMLC;
mutations T18A, S19A) in A3 cells. Control cells (A3GFP)
expressing only GFP were prepared as well. The presence
of GFP-tagged recombinant proteins in A3 cells was con-
firmed by immunodetection (Figure 1A) and the resulting
cell lines were analyzed for invasiveness and morphology
in 3D collagen. Consistently with our previous analysis of
the invasiveness of A3 cells by a Matrigel invasion assay
[11], we found that A3 cell invasiveness in 3D collagen is
greatly decreased in the presence of ROCK inhibitor Y-
27632 or non-muscle myosin II ATPases activity inhibitor
Blebbistatin and insensitive to the presence of a broad-
spectrum metalloproteinase inhibitor, GM6001. Expres-
sion of both dominant negative Rho and MLC resulted in
the greatly decreased capability of cells to invade a 3D
collagen gel (Figure 1B), confirming their dominant nega-
tive effect on Rho and MLC signaling, respectively. Next,
we analyzed the effect of Rho/ROCK/MLC inhibition onthe morphology of cells in 3D collagen. Inhibition of Rho
activity by the expression of dnRhoA or inhibition of
ROCK by Y-27632 led to the amoeboid-mesenchymal
transition in A3 cells. Surprisingly, inhibition of MLC
activity by the expression of dnMLC and inhibition of
non-muscle myosin II ATPases activity by Blebbistatin,
despite their inhibitory effect on invasiveness, did not led
to a significant change in A3 cell morphology in 3D colla-
gen (Figure 1C and Additional file 1: Figure S1).
To visualize the shape of cells and interactions
between cells and the extracellular matrix in detail, the
cells were seeded on a dermis-based matrix and visualized
by scanning electron microscopy (SEM). We have pre-
viously successfully used this substrate, which closely
resembles the biochemical and biomechanical properties
of the matrix in tissues, to elucidate the structure of
invadopodia [18] as well as the structure and dynamics of
focal adhesions [19] in a complex 3D environment. The
A3 cells visualized by SEM during the initial steps of
dermis-based matrix invasion exhibited a rounded mor-
phology and did not seem to cleave collagen fibers. Rather,
they appeared to push themselves beneath the sheet of
collagen fibers (Figure 2A). This rounded morphology and
invasion without obvious cleavage of collagen fibers was
also observed for A3 cells invading isolated fascia of a rat
diaphragm (Additional file 2: Figure S2). In contrast,
closely related but mesenchymally invading RsK4 cells
[18] were typically positioned partially inside a cavity in
the dermis, which was apparently formed by the degrad-
ation of matrix fibers (Figure 2B). 3D scanning of the
dermis-based matrix by confocal microscopy further
revealed that A3 cells effectively invaded the matrix even
in the presence of a broad-spectrum MMP-inhibitor,
without noticeable degradation of the collagen fibers
(Figure 2C). In contrast and consistent with the SEM
results (Figure 2B), K4 cells have previously been shown
to extensively degrade the matrix in the absence of inhibi-
tor, whereas in the presence of an MMP inhibitor they
were not able to invade and the matrix remained mostly
intact [18].
The Rho/ROCK/MLC pathway is critical for the invasion of
highly metastatic chicken PR9692 sarcoma cells into a 3D
collagen matrix
To verify our observations of amoeboid invasiveness in rat
sarcoma cells, we next wanted to analyze an independent
amoeboid sarcoma cell line from another organism. We
chose a chicken sarcoma model of metastasis consisting of
the parental highly metastatic PR9692 cell line and the
non-metastatic PR9692-E9 cell line (a subclone of PR9692
cells) [20]. Both PR9692 and PR9692-E9 cells give rise to
rapidly growing sarcomas. While tumors induced by
parental PR9692 cells efficiently metastasize into lungs,
PR9692-E9 tumors never metastasize. Microarray analysis
Figure 1 Effects of Rho, ROCK, MLC signaling inhibition on the invasiveness and morphology of A3 rat cells. (A) Immunodetection of
GFP-tagged RhoA and MLC proteins in A3 cells. (B) The in vitro invasion of A3 cells in 3D collagen. Treatment of A3 cells with metalloproteinase
inhibitor GM6001 has no significant effect on invasion. Inhibition of ROCK by Y-27632 and inhibition of non-muscle myosin II ATPases activity by
Blebbistatin in A3 cells as well as inhibition of both RhoA in A3dnRhoA cells and MLC in A3dnMLC cells leads to decreased ability of these cell
lines to invade 3D collagen. (C) Morphology of A3 cells in 3D collagen in vitro. Activity of RhoA and ROCK is required for rounded morphology of
the A3 cell line. Inhibition of ROCK by Y-27632 and inhibition of RhoA in A3dnRhoA lead to the amoeboid-mesenchymal transition in 3D
collagen. Inhibition of metalloproteinases by GM6001, inhibition of non-muscle myosin II ATPases activity by Blebbistatin in A3 cells and inhibition
of MLC activity in A3dnMLC cells has no significant effect on morphology.
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Figure 2 A3 cells use the amoeboid mode of invasion. Initial steps of dermis-based matrix invasion were visualized by scanning electron
microscopy. (A) A3 cells maintain rounded morphology, and during invasion they appear to push themselves under extracellular matrix fibers.
Scale bar 5 μm. (B) RsK4 cells are positioned partially inside a cavity and are surrounded with wrapped fibers. Scale bar 5 μm. (C) Invasive
capability of A3 cells is not affected by the presence of 20 μM metalloproteinase inhibitor GM6001 (as also shown in Figure 1). A3 cells were
seeded on FITC-stained dermis (green) and after 3 days were fixed and stained by Phalloidin for F-actin (red) and by DAPI for nuclei (blue). The
images series represent serial optical sections captured at 10 μm intervals from top of dermis-based matrix (0 μm) to 40 μm of invasion depth.
Scale bars 10 μm.
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PR9692-E9 have revealed an almost 80 fold increased
expression of myl9 (myosin regulatory light chain 2, mlc2)
mRNA in PR9692 cells [20], suggestive of the potentially
increased actomyosin contractility of PR9692 cells. Using
the 3D invasion assay we confirmed that metastatic
PR9692 cells are more invasive than non-metastatic
PR9692-E9 cells (Figure 3A). An analysis of morphology
in 3D collagen revealed that PR9692 cells adopt a rounded
morphology in a 3D environment (Figure 4C, Additional
file 1: Figure S1).To confirm the amoeboid phenotype of PR9692 cells
we tested their sensitivity to ROCK inhibitor as well as
the expression of extracellular matrix proteases. The
analyses revealed that PR9692 cells produce smaller
amount of both MT1-MMP (MMP14) and MMP-2 than
PR9692-E9 cells (Figure 3B and C). The addition of
ROCK inhibitor to PR9692 cells greatly inhibited their
invasiveness, even below the invasive capacity of PR9692-
E9 (Figures 3A and 4B), and induced an effective
amoeboid-mesenchymal transition (Figure 4C, Additional
file 1: Figure S1). Conversely, the cells were insensitive to
Figure 3 Metastatic PR9692 cells adopted the amoeboid mode of invasion while non-metastatic PR9692-E9 cells use the mesenchymal
mode. (A) 3D in vitro collagen invasion. (B) Immunochemical detection of MT1-MMP (MMP14) protein levels. (C) Activity of MMP-2
metalloproteinase detected by gelatin zymography.
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(Figure 4C). Taken together, these results confirm the
amoeboid nature of PR9692 cells. To inhibit RhoA and
MLC signaling in PR9692 cells, replication-defective
viruses encoding dominant negative RhoA (dnRho; inacti-
vating mutation T19N) or non-phosphorylable MLC
(dnMLC; mutations T18A, S19A) were used to infect
PR9692 cells. The resulting cells were screened for the
presence of GFP-tagged dnRhoA and dnMLC by immu-
noblotting. Detected protein levels of dnRhoA and
dnMLC varied, probably reflecting the cellular regulation
of these proteins’ different stability, as the extent of viral
integration and expression in infected cells shown by the
immunodetection of neomycin phosphotransferase II
(NPT II) was very similar (Figure 4A).
We then explored the effect of Rho, MLC and non-
muscle myosin II ATPases activity inhibition on PR9692
cell invasiveness in 3D collagen. We found that all Rho,
MLC and non-muscle myosin II ATPases activity in-
hibition resulted in great decrease of the capability of
PR9692 cells to invade a 3D collagen gel (Figure 4B).
Next, we analyzed the effect of Rho/ROCK/MLC in-
hibition on the morphology of cells in 3D collagen. We
found that while inhibition of Rho activity by the ex-
pression of dnRhoA or inhibition of ROCK by Y-27632
led to the amoeboid-mesenchymal transition, MLC
inhibition, treatment with the metalloproteinase inhibi-
tor GM6001 or non-muscle myosin II ATPases activity
inhibitor Blebbistatin did not lead to a significantchange in cell morphology in 3D collagen (Figure 4C,
Additional file 1: Figure S1). Taken together, these
results suggest the important role of RhoA and ROCK
activity as well as the phosphorylation of MLC and
non-muscle myosin II ATPases activity in the invasive-
ness of highly metastatic PR9692 sarcoma cells into 3D
collagen.
The Rho/ROCK/MLC pathway is critical for the metastatic
capability of PR9692 cells
To examine the role of RhoA activation and MLC phos-
phorylation in the in vivo metastatic capacity of PR9692
cells, animals were injected with PR9692-mock, PR9692-
dnMLC, and PR9692-dnRhoA cells. The animals were
killed 21, 28 and 35 days post-injection (d.p.i.) and their
lungs inspected for the presence of metastases. The
extent of metastases was expressed by three categories
representing the number and size of metastases. Exam-
ples of these three categories are shown in Figure 5. The
size of the primary tumor did not correlate with the
number and size of metastases or proliferation rate of
cells in vitro as there is basically no effect of caRhoA,
dnRhoA or dnMLC on growth of cells in comparison
with MOCK in vitro (Additional file 3: Table S1 and
Additional file 4: Table S2). The difference in prolifera-
tion between infected (MOCK, caRhoA, dnRhoA and
dnMLC) and not infected cells is negligible (maximally
7% of not-infected cells’ doubling time) (Additional file 3:
Table S1 and Additional file 4: Table S2). We found that
Figure 4 Effect of Rho, ROCK, MLC signaling inhibition on the
invasiveness and morphology of PR9692 cells. (A)
Immunodetection of recombinant dnRhoA, dnMLC and NPTII
proteins in PR9692 cells. (B) 3D in vitro collagen invasion. Treatment
of PR9692 cells with metalloproteinase inhibitor GM6001 does not
reduce the cell invasion. Inhibition of ROCK by Y-27632 and
inhibition of non-muscle myosin II ATPases activity by Blebbistatin in
PR9692 cells as well as inhibition of both RhoA in PR9692-dnRhoA
and MLC in PR9692-dnMLC lead to decreased ability of these cell
lines to invade 3D collagen. (C) Morphology assay in 3D collagen
in vitro. Activity of RhoA is required for the rounded morphology of
the PR9692 cell line. Inhibition of ROCK by Y-27632 and inhibition of
RhoA in PR9692-dnRhoA lead to the amoeboid-mesenchymal
transition in 3D collagen. Inhibition of metalloproteinases by
GM6001, inhibition of non-muscle myosin II ATPases activity by
Blebbistatin in PR9692 cells and inhibition of MLC activity in PR9692-
dnMLC cells have no significant effect on morphology.
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inhibition of MLC activity in PR9692-dnMLC (both lead
to decreased invasion in 3D collagen in vitro) led to a
great decrease in the metastatic activity of these cells. A
reduction of metastatic spreading was detected in most of
animals injected with either PR9692-dnRhoA or PR9692-
dnMLC cells when compared with PR9692-mock cells or
PR9692 cells. While PR9692-mock cells or PR9692 cells
formed metastases in 100% of cases, only about 50% of
animals injected with both PR9692-dnRhoA and PR9692-
dnMLC gave rise to metastases. Importantly, the size and
number of metastatic foci in animals injected with
PR9692-dnRhoA was reproducibly smaller in comparison
to those induced by PR9692-mock cells or PR9692
(Figure 6 and Additional file 3: Table S1). Taken
together, these results suggest the important role of
RhoA and ROCK activity as well as the phosphory-
lation of MLC in the in vivo metastasis of PR9692
sarcoma cells.
Activation of RhoA in non-metastatic PR9692-E9 cells
results in rescue of the invasive and metastatic capability
of these cells
Finally, we wondered whether the activation of Rho/ROCK/
MLC signaling through the expression of constitutive-active
RhoA (caRhoA, activating mutationG14V) would result in
rescue of the metastatic capability of non-metastatic
PR9692-E9 cells. Replication-defective viruses encoding
caRhoA were used to infect PR9692-E9 cells. Control cells
infected with empty SFCV-LE retroviral vector (PR9692-
E9-mock) were prepared in the same fashion. The
resulting cells, resistant to G418, were screened for the
presence of GFP-tagged caRhoA as well as NPT II by
immunoblotting to show that the extent of viral integra-
tion and expression was very similar in both infected cells
(Figure 7A). We first compared the invasive capability of
PR9692-E9 and PR9692-E9-caRhoA cells in a 3D collagen
Figure 5 Categories of lung metastases according to sizes and numbers of tumors. (A) no metastases (B) +, multiple (>10) small (indicated
by arrowheads) and 1–3 medium sized (3–4 mm) metastases; (C) ++, multiple small and more than 3 medium sized metastases and/or 1–3 large
(4–5 mm) isolated metastases; (D) +++, lungs overgrown with medium to large metastases growing together, frequently more than 50% of lungs
formed by tumor tissue; (E) in some chicks metastases seized the majority of the lungs. Scale bar 1 cm.
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have a much greater capability to invade 3D collagen com-
pared to the PR9692-E9 cell line or PR9692-E9-mock cells
(Figure 7B). Next we compared the metastatic potential of
PR9692-E9, PR9692-E9-mock and PR9692-E9-caRhoAcells. Lungs of animals injected with PR9692-E9, PR9692-
E9-mock or PR9692-E9-caRhoA cells were inspected for
the presence of metastases 28, 35 and 45 days post-
injection. We found that the activation of RhoA signaling
in PR9692-E9-caRhoA cells led to a restoration of
Figure 6 Effect of Rho and MLC signaling inhibition on the
metastatic activity of PR9692 cells. Inhibition of RhoA signaling in
PR9692-dnRhoA and inhibition of MLC activity in PR9692-dnMLC led
to the decreased metastatic activity of PR9692 cells.
Figure 7 Activation of RhoA leads to increased invasive
potential in PR9692-E9 cells. (A) Immunochemical analysis of
recombinant caRhoA proteins in PR9692-E9-caRhoA cells. GFP-
tagged full-length proteins are indicated by the arrowhead. (B) 3D
in vitro collagen invasion.
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ing all three metastatic categories, was detected in about
55% of animals injected with PR9692-E9-caRhoA cells,
while no metastasis was detected in animals injected with
PR9692-E9 or PR9692-E9-mock cells (Figure 8 and
Additional file 4: Table S2). Taken together, these re-
sults suggest that the activation of Rho/ROCK/MLC sig-
naling through the expression of constitutive-active RhoA
is sufficient to rescue the invasive and metastatic capabil-
ity of non-metastatic PR9692-E9 cells.
Discussion
Amoeboid invasiveness in vitro was for the first time de-
scribed in 2003 [8,9] and has been studied extensively
since then. However, its relevancy for invasiveness and
metastasis in vivo is still not clear. Sabeh et al. [21]
suggested that the amoeboid invasiveness of tumor cells
observed in vivo can only occur under specific con-
ditions and may not be an effective and widespread
alternative to protease-dependent tumor cell migration
[21]. Yet, several studies have provided evidence for the
plausibility of amoeboid invasion in vivo and Rho/ROCK
dependent metastasis.
Initially, indirect supportive evidence for possible
involvement of amoeboid invasiveness in the process of
in vivo metastasis came from clinical studies with ROCK
kinase inhibitors (reviewed in [22]). The ROCK kinase
inhibitor fasudil was shown to reduce the dissemination
of cancer in the peritoneal cavity, blood-borne metasta-
sis to the lung, and prevent the establishment of breast
tumors in the mammary fat pad [23]. Similarly, Y-27632
was shown to inhibit the tumor growth and intrahepatic
metastasis of hepatocellular carcinoma [24]. In none
of these studies, however, were cells with a defined
protease-independent amoeboid invasiveness used. At
least two independent studies have associated signalingchanges leading to microtubule destabilization with the
rounded morphology associated with increased invasion
and metastatic potential. Hager et al. observed that
DIAPH3 silencing in human carcinoma cells resulted in
microtubule destabilization, a rounded morphology, and
enhanced MYPT1 phosphorylation associated with
increased invasive capability and metastatic potential in
mice [25]. Belleti et al. found that stathmin stimulated cell
motility through the extracellular matrix in vitro and
increased the metastatic potential of sarcoma cells in vivo.
Accordingly, a less phosphorylable stathmin point mutant
impaired ECM-induced microtubule stabilization and
conferred a higher invasive potential, inducing a rounded
cell shape coupled with amoeboid-like motility in three-
dimensional matrices [26]. In neither of these studies,
however, did the authors show that the invasion of the
Figure 8 Activation of RhoA signaling in PR9692-E9-caRhoA cells
led to the restoration of metastatic potential of PR9692-E9.
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dependent.
The most convincing evidence to date for the role of
protease-independent invasiveness in the process of
in vivo metastasis was given by the Chiarugi lab in a
series of studies analyzing the role of EphA2 in the
metastasis of melanoma [27] and prostate carcinoma
[28] cells. The authors showed that EphA2 re-expression
in B16 murine melanoma cells converts their migration
style from a mesenchymal to an amoeboid-like nonpro-
teolytic invasive program, giving rise to successful lung
and peritoneal lymph node metastases. [27]. They also
showed that EphA2 expression in prostate carcinoma
cells results in Rho-mediated cell rounding and independ-
ence from metalloproteinases, associated with increased
metastatic potential [28]. In the only study so far analyzing
the influence of direct manipulation of Rho/ROCK signal-
ing on invasive and metastatic potential, Belgiovine et al.
investigated the acquisition and molecular regulation of
the invasive capacity of neoplastically transformed human
fibroblasts, which were able to induce metastatic sarcomas
when injected into immunocompromised mice. The cells
showed a rounded morphology in the 3D environment
and their invasiveness was sensitive to ROCK inhibitor,
but not to a matrix protease inhibitor. The increased
invasiveness of the cells was associated with the reduced
expression of RhoE, a cellular inhibitor of ROCK. The
ectopic RhoE expression reduced their invasive ability
in vitro and their metastatic potential in vivo [29].
In our study we used two well characterized and
defined independent lines of primarily amoeboid meta-
static sarcoma cells with no detectable gelatinase activity
from two different organisms. The protease-independent
and ROCK-dependent movement of both A3 and PR9692
amoeboid sarcoma cells was initially shown in a 3D colla-
gen invasion assays. Furthermore, to analyze the amoeboid
invasiveness in a complex 3D environment, we used ourmodel of acellular dermis, a substrate with biochemical
and biomechanical properties very similar to that in tissue
that we previously successfully used to elucidate the
structure of invadopodia [18]. Our highly metastatic A3
sarcoma cells were able to effectively invade the acellular
dermis irrespective of the presence of MMP inhibitor,
further confirming the capability of sarcoma cells to
effectively invade in a tissue-like environment.
We show that the metastatic capability of amoeboid
sarcoma cells in vivo is dependent not only on RhoA
activity, but also on MLC phosphorylation status. We
believe this is the first direct evidence for the importance
of MLC phosphorylation status for the metastatic capa-
bility of cancer cells. Our data show that the activation
of Rho, ROCK, the phosphorylation of MLC and non-
muscle myosin II ATPases activity is necessary for effect-
ive invasiveness of both A3 and PR9692 sarcoma cells,
and that the activation of Rho and MLC phosphorylation
is necessary for the effective metastasis of PR9692 cells.
However, our data also suggest that activation of Rho and
ROCK but not MLC phosphorylation or non-muscle
myosin II ATPases activity is required to maintain the
rounded morphology of the sarcoma cells. This would
imply a model (Figure 9) according to which signaling for
the maintenance of rounded morphology is at least in part
different from signaling enabling effective amoeboid
invasiveness.
Conclusions
Our study is the first study to show the effective
amoeboid invasion and metastasis of cancer cells in a
non-mammalian system, which further supports the
general importance of the phenomena of amoeboid
invasion and also opens up possibilities for introducing
novel and powerful models, such as a syngeneic chicken
model for the in vivo analysis of amoeboid cancer cell
metastasis. Together with previous studies from the
Mondello and Chiarugi labs, we believe our data provide
the strongest evidence to date for the capability of
amoeboid cancer cells to invade the tissue environment
and effectively metastasize in vivo.
Methods
Establishment of stable cell lines and cell cultures
A3 cells (full name A337/311RP) and RsK4 cells were
developed as described previously [30,31]. The A3dnRhoA
and A3dnMLC cell lines were prepared to stably express
either a GFP-fused dominant negative RhoA (mutations
F25N, T19N; [32]) from pEGFP-dnRhoA or a non-
phosphorylable (dominant negative) GFP-fused MLC
(mutations T18A, S19A; [33]) by selection in G418 at 400
μg/ml and subsequent FACS sorting of GFP-positive cells
(FACSVantage SE, BD Biosciences). Cells A3GFP were











Figure 9 Rho signaling in the maintenance of amoeboid morphology and invasion/metastasis of sarcoma cells. The activation of Rho,
ROCK and the phosphorylation of MLC are all crucial for the effective invasiveness/metastasis of amoeboid sarcoma cells. In contrast, the rounded
morphology of amoeboid sarcoma cells is not dependent on MLC phosphorylation or non-muscle myosin II ATPase activity, suggesting another
downstream effectors of Rho/ROCK pathway are involved in the maintenance of rounded morphology of cancer cells.
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medium: DMEM (GIBCO) with 4500 mg/l L-glucose, L-
glutamine, and pyruvate, supplemented with 10% fetal
bovine serum (Sigma), 2% antibiotic-antimycotic (GIBCO)
and 1% MEM non-essential amino acids (GIBCO) kept at
37°C in a humidified atmosphere with 5% CO2. The cell
lines PR9692, PR9692-E9 and PR9692-E9-MOCK were
established as described previously [20]. The cell lines
PR9692-dnRhoA, PR9692-dnMLCMLC, PR9692-MOCK,
and PR9692-E9-caRhoA were prepared in the same fash-
ion as PR9692-E9-MOCK using the appropriate SFCV-LE
vectors (SFCV-GFP-dnRhoA, SFCV-dnMLC-GFP, SFCV-
LE, SFCV-GFP-caRhoA, respectively), the PR9692 or
PR9692-E9 cell lines, and the KUNDRA packaging cell
line. After transfection, individual clones of G418 resistant
cells were tested for the expression of appropriate con-
structs by immunoblotting. All chicken cells were main-
tained in Dulbecco‘s modified Eagle’s medium (DMEM,
Sigma) supplemented with L-glutamine, penicillin, strep-
tomycin, 4% fetal calf serum (PAA) and 2% chicken serum
(Sigma) at 41°C in a humidified atmosphere with 5% CO2.
Cells were treated with inhibitors 20 μM GM6001 (Sigma),
10 μM Y-27632 (Sigma), and 50 μM Blebbistatin (Sigma).
The doubling time of cell lines was determined as a mean
value of three doubling times counted in consecutive
passages of cells in exponential phase of growth.
DNA constructs
SFCV-GFP-dnRhoA was constructed by introducing
GFP-dnRhoA (EcoRI – NheI) from pEGFP-dnRhoA [32]
between the XbaI and EcoRI sites of the pSFCV-LE vector.
SFCV-GFP-caRhoA was constructed based on pEGFP-
caRhoA (bearing RhoA with mutations F25N, G14V) [32]
similarly to SFCV-GFP-dnRhoA. SFCV-dnMLC-GFP was
constructed by introducing dnMLC-GFP (HindIII – NotI,
Pfu polymerase blunted) from pEGFP-dnMLC [33] bet-
ween the HindIII and EcoRV sites of the pSFCV-LE
vector.
Immunoblotting
For protein analysis, cells were plated onto 100-mm
dishes and grown until subconfluent. Before lysis, the
cells were transferred into 15-ml tubes and centrifuged.
The pellets were dissolved in 500 μl of LysBuf (20 mMTris pH 6.8, 1% Triton X-100, 0.3% SDS, 5 mM EDTA,
10% glycerol, protease inhibitor cocktail Complete,
EDTA-free from Roche) and the lysate was aspirated
and transferred to a 1.5 ml tube. The lysates were
cleared by centrifugation at 15,000 rpm for 20 min. Pro-
tein concentration was assayed by the bicinchonic acid
method (Pierce), the lysates were diluted to equal
concentration with LysBuf, mixed with 5× SB (300 mM
Tris pH 6.8, 5% SDS, 360 mM 2-mercaptoethanol, 50%
glycerol, 0.05% bromphenol blue) and incubated at 99°C
for 10 min. Proteins (40 μg/lane) were separated on a
10% polyacrylamide gel by SDS-PAGE and transferred to
nitrocellulose membranes (Amersham Hybond-ECL).
Membranes were probed with primary antibodies specific
for GFP (sc-9996, Santa Cruz Biotechnology, 1:1,000),
NPTII (#06-747, Millipore, 1:2,000) and MT-MMP1 (sc-
12366, Santa Cruz Biotechnology, 1:1,000). Membranes
were then incubated with the appropriate secondary
antibodies (Jackson ImmunoResearch Laboratories) and
subjected to enhanced chemiluminescence detection. For
sequential detections, membranes were stripped with
Re-Blot Plus Mild Antibody Stripping Solution (Millipore).
Equal protein loading and transfer was verified by Ponceau-
S staining of each membrane and by performing detection
of GAPDH using antibody GTX30666 (GeneTex, 1:2,000)
on the same membrane.
In-gel gelatin zymography
In total, 2 × 105 cells were plated per well in a 24-well
plate. After 16 h, cells were washed with PBS and incu-
bated in 300 μl of serum-free medium for 72 h. Aliquots
(25 μl) of the conditioned medium were loaded for
zymography on a 10% SDS-PAGE gel containing 1 mg/ml
gelatin. Briefly, gel proteins were washed for 1 h in
50 mmol/l Tris–HCl (pH 7.5), 0.1 mol/l NaCl, and
2.5% Triton X-100 and then incubated at 37°C in 50 mmol/l
Tris–HCl (pH 7.5), 10 mmol/l CaCl2, and 0.02%
sodium azide for 17 h. The gels were stained with
Coomassie blue and destained in 7% acetic acid/5%
methanol.
In vitro cell invasion assays in 3D collagen
The 3D collagen invasion assay was analyzed as described
previously [34]. Briefly, cell suspension (2 × 105 cells/ml)
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and after 48 hours the level of invasion was measured as
the average invasion depth of the cells in the selected field
of view using a Nikon-Eclipse TE2000-S (20×/0.40 HMC
objective) and NIS-Elements software. For each experi-
ment, invasion was analyzed in 3 wells and in 6 fields of
view per individual well. In order to compare individual
experiments, the average invasion depth was normalized
to that of untreated cells. Three independent experiments
were analyzed for each condition. Significance of diffe-
rences was analyzed with ANOVA followed by Tukey’s
honest significant difference test. The analysis was perfor-
med in version 2.15.3R (R Core Team, 2013. R: A language
and environment for statistical computing. R Foundation
for Statistical Computing, Vienna, Austria. ISBN 3-900051-
07-0, URL http://www.R-project.org/).
Cell morphology assays in 3D collagen
To analyze cell morphology in 3D collagen, cells were
trypsinized, washed in complete medium, counted, and
then 105 cells were mixed with 500 μl of 3 mg/ml Colla-
gen R in complete medium. This suspension of cells in
collagen (500 μl) was loaded into a well of a 12-well
plate, the gel was allowed to polymerize at 37°C for 30
min, and was then overlaid with complete medium.
After 24 h the morphology of cells in 3D collagen was
analyzed using the Nikon Eclipse TE2000-S microscope
(20×/0,40 HMC objective). Cell morphology was classi-
fied on the basis of the elongation index. The elongation
index was calculated as the length divided by the width.
Cells whose elongation index was greater than 3 were con-
sidered elongated. Intermediate cells had an elongation
index of 2–3; for rounded cells, the index was 1–2. Divi-
ding cells were excluded from the analysis. Three
independent experiments (at least 300 cells per experi-
ment) were analyzed for each condition. As the data
have the form of counts in categories, the Pearson's
Chi-squared test was used to reveal statistically signifi-
cant differences.
Dermis-based matrix
For immunofluorescence staining the following proced-
ure was used: two days before use the dermis-based
matrix (XeDerma®; BIO SKIN a.s.) was cut into small
pieces (approx. 1x1 cm), placed into 12 wells plates with
HBSS buffer, and just prior to use washed twice with
DMEM medium and cells were seeded on the epidermal
side of the dermis. After incubation the dermis was
washed with PBS and fixed. For labeling the dermis was
pre incubated for two days in HBSS buffer. The
conjugation of FITC (1 μg/ml; Molecular Probes) was
performed in 0.1 M sodium bicarbonate buffer, pH.9.0
for 30 min and then the unconjugated dye was washed
off three times with PBS and two times with DMEM.Scanning electron microscopy
Cells in full DMEM medium were grown on dermis-
based matrix for 24 hours, and for the next 24 hours in
serum free DMEM. The dermis-based matrix with cells
was washed two times in PBS, fixed in 2.5% glutaralde-
hyde, and washed again three times. Dehydration in
increasing concentrations of ethanol (10 min. each for
30%, 50%, 70%, 80%, 90%, 95 and 100%) was followed by
critical point drying using CPD 030 (BAL TEC), coated
with 3 nm gold on Sputter Coater SCD 050 (BAL TEC)
and visualized by SEM on a JEOL 6380 LV. Rat fascia
freshly removed from an adult rat was immobilized in a
frame, positioned inside 6-well plates, and cells were
seeded on top. After 2 days the whole frame was
fixed and processed the same ways as dermis-based
matrix.
Immunofluorescence microscopy
Cells on epidermal side of dermis-based matrix were fixed
in 4% paraformaldehyde, permeabilized in 0.5% Triton X
100, washed thrice with PBS, and stained for 15 min with
Alexa 594 phalloidin (Molecular Probes) and then washed
thrice with PBS and mounted in Mowiol containing 4',6-
diamidino-2-phenylindole (DAPI, Sigma). Images were
acquired by a Leica TCS SP2 microscope system using a
Leica 20×/0.7 oil objective.
Animals
Experiments were done with the Prague inbred chicken
line CC.R1 [35]. All procedures were performed in
accordance with the Guide for the Care and Use of
Laboratory Animals and approved by the Animal Care
and Use Committee of the Academy of Sciences of
the Czech Republic. Chicks were kept under standard
laboratory conditions with free access to food and
water.
Monitoring of tumor weight and metastases
Chickens were inoculated by injection into the outer
area of the pectoral muscle at an age of 3 weeks with
5×105tumor cells that had been freshly harvested from
the tissue culture and resuspended in 0.2 ml of cultiva-
tion medium. The weight of the primary tumor and
spontaneous metastatic activity of each tumor cell line
were determined by examining chickens autopsied from
21 to 35 and from 28 to 45 days after inoculation with
cells derived from the PR9692 cells and PR9692-E9 cells,
respectively. The time of autopsy reflected the health
status of the animals. Metastases were observed by gross
inspection and using a dissection microscope. The expe-
riments were performed several times with a total num-
ber of at least 33 animals in each group, except for the
control groups where the numbers were slightly reduced
(26) to spare animals.
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Additional file 1: Figure S1. Effect of Rho, ROCK, MLC signaling
inhibition on morphology of A3 and PR9692 amoeboid cells.
Representative figures of cell morphology in 3D collagen in vitro; scale
bars 100 μm.
Additional file 2: Figure S2. Amoeboid mode of invasion of A3 tested
on abdominal rat fascia. A3 cells maintain rounded morphology. No
disrupted fibers, an indication of degradation activity, can be seen in
proximity of the cells. Two representative images are shown. Scale bars 5 μm.
Additional file 3: Table S1. Detailed description of in vivo experiments
with cells derived from PR9692 cells. Detailed results including doubling
time of cells, weight of primary tumor and metastatic category of
appropriate lung metastases in particular animals.
Additional file 4: Table S2. Detailed description of in vivo experiments
with cells derived from PR9692-E9 cells. Detailed results including
doubling time of cells, weight of primary tumor and metastatic category
of appropriate lung metastases in particular animals.
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